BACKGROUND AND AIM: Tissue injury leads to activation of coagulation and generation of thrombin. Inhibition of thrombin receptor protease-activated receptor 1 (PAR-1) has been shown to reduce liver fibrosis in animals. This study aimed to evaluate the effect of PAR-1 gene polymorphism on rate of liver fibrosis (RF) in chronic hepatitis C. METHODS: Polymorphisms studied: C > T transition 1426 bp upstream of translation start site (-1426C/T), 13 bp repeat of preceding -506 5'-CGGCCGCGGGAAG-3' sequence (-506I/D), and A > T transversion in intervening sequence (IVS) 14 bp upstream of exon-2 start site (IVS-14A/T). A total of 287 European and 90 Brazilian patients were studied. RESULTS: 1426C/T polymorphism: There was a trend to higher RF in patients with the TT genotype (P = 0.06) and an association between genotype CC and slow fibrosis (P = 0.03) in Europeans. In males, RF was significantly higher in those with the TT genotype compared to CT (P = 0.003) and CC (P = 0.007). There was a significant association between TT and fast fibrosis (P = 0.04). This was confirmed in an independent cohort of Brazilians where RF was higher in TT than in CC (P = 0.03). Analysis of -506I/D showed no difference in RF and distribution of slow/fast fibrosis among different genotypes in both populations. Analysis of IVS-14A/T showed no difference between genotypes. CONCLUSION: In conclusion, these findings suggest that PAR-1 receptor polymorphisms influence the progression of liver fibrosis.
BACKGROUND AND AIM: Tissue injury leads to activation of coagulation and generation of thrombin. Inhibition of thrombin receptor protease-activated receptor 1 (PAR-1) has been shown to reduce liver fibrosis in animals. This study aimed to evaluate the effect of PAR-1 gene polymorphism on rate of liver fibrosis (RF) in chronic hepatitis C. METHODS: Polymorphisms studied: C > T transition 1426 bp upstream of translation start site (-1426C/T), 13 bp repeat of preceding -506 5'-CGGCCGCGGGAAG-3' sequence (-506I/D), and A > T transversion in intervening sequence (IVS) 14 bp upstream of exon-2 start site (IVS-14A/T). A total of 287 European and 90 Brazilian patients were studied. RESULTS:1426C/T polymorphism: There was a trend to higher RF in patients with the TT genotype (P = 0.06) and an association between genotype CC and slow fibrosis (P = 0.03) in Europeans. In males, RF was significantly higher in those with the TT genotype compared to CT (P = 0.003) and CC (P = 0.007). There was a significant association between TT and fast fibrosis (P = 0.04). This was confirmed in an independent cohort of Brazilians where RF was higher in TT than in CC (P = 0.03). Analysis of -506I/D showed no difference in RF and distribution of slow/fast fibrosis among different genotypes in both populations. Analysis of IVS-14A/T showed no difference between genotypes. CONCLUSION: In conclusion, these findings suggest that PAR-1 receptor polymorphisms influence the progression of liver fibrosis.
Authors: Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite Journal: Front Immunol Date: 2015-06-08 Impact factor: 7.561
Authors: Jinsheng Guo; Feng Hong; Johnny Loke; Steven Yea; Chooi Ling Lim; Ursula Lee; Derek A Mann; Martin J Walsh; John J Sninsky; Scott L Friedman Journal: J Biol Chem Date: 2009-12-17 Impact factor: 5.157
Authors: Barry S Shea; Clemens K Probst; Patricia L Brazee; Nicholas J Rotile; Francesco Blasi; Paul H Weinreb; Katharine E Black; David E Sosnovik; Elizabeth M Van Cott; Shelia M Violette; Peter Caravan; Andrew M Tager Journal: JCI Insight Date: 2017-05-04
Authors: Ameet Dhar; Fouzia Sadiq; Quentin M Anstee; Adam P Levene; Robert D Goldin; Mark R Thursz Journal: BMC Gastroenterol Date: 2018-05-08 Impact factor: 3.067
Authors: Yiannis N Kallis; Christopher J Scotton; Alison C Mackinnon; Robert D Goldin; Nicholas A Wright; John P Iredale; Rachel C Chambers; Stuart J Forbes Journal: PLoS One Date: 2014-01-27 Impact factor: 3.240
Authors: Manuela Platé; Phillippa J Lawson; Michael R Hill; Jennifer K Quint; Meena Kumari; Geoffrey J Laurent; Jadwiga A Wedzicha; Rachel C Chambers; John R Hurst Journal: Am J Physiol Lung Cell Mol Physiol Date: 2014-06-27 Impact factor: 5.464